Mi SciELO
Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Citado por Google
- Similares en SciELO
- Similares en Google
Compartir
Revista de Osteoporosis y Metabolismo Mineral
versión On-line ISSN 2173-2345versión impresa ISSN 1889-836X
Resumen
MORAN-LOPEZ, JM; CRESPO-GUTIERREZ, J y PUECH-DE ORIOL, M. Teriparatide in the substitutive treatment of chronic hypoparathyroidism. About a case. Rev Osteoporos Metab Miner [online]. 2022, vol.14, n.4, pp.104-106. Epub 27-Mar-2023. ISSN 2173-2345. https://dx.doi.org/10.4321/s1889-836x2022000400002.
Objetive:
To report experience in the use of teriparatide as an effective replacement therapy for chronic hypoparathy roidism.
Material and methods:
The clinical case of a patient with post‐surgical chronic hypoparathyroidism who previously presented difficult control with conventional treatment (calcium salts and calcitriol) is presented, for which teriparatide was started as a substitute treatment.
Results:
The patient presented analytical values of phosphocalcic metabolism compatible with normality from the 4th week of treatment with teriparatide, allowing the suspension of previous treatments and maintaining good control one year after the change in therapy.
Conclusions:
Teriparatide is an effective option for treating chronic hypoparathyroidism. We have observed a latency phase until the hormonal effect begins, so we recommend frequent analytical monitoring and gradually reduce treatment with calcitriol and calcium salts for adequate control.
Palabras clave : teriparatida; hipoparatiroidismo; crónico; postquirúrgico; tratamiento.